Health Tech Startup OpenEvidence Sues Doximity for Alleged Reverse Engineering of AI Technology

Health tech startup OpenEvidence Inc. has initiated legal proceedings against Doximity Inc., a prominent online medical networking platform, accusing it of reverse-engineering its proprietary AI technology through a methodology known as “prompt injections.” The complaint, filed by the renowned law firm Quinn Emanuel Urquhart & Sullivan, cites several alleged violations, including the Defend Trade Secrets Act and the Computer Fraud and Abuse Act. OpenEvidence contends that Doximity executed cyberattacks, impersonating real physicians to extract sensitive information and develop its own competing AI tool. Additionally, OpenEvidence’s representative, Stephen Broome, underscored that while the complaint presents novel technology issues, the fundamental legal protection of the underlying computer code remains intact. For more information, the lawsuit filing is available here.